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Stem cells (SC) are among the most promising cell sources for tissue engineering due to their ability to self-renew and differentiate,
properties that underpin their clinical application in tissue regeneration. As such, control of SC fate is one of the most crucial
issues that needs to be fully understood to realise their tremendous potential in regenerative biology. The use of functionalized
nanostructured materials (NM) to control the microscale regulation of SC has offered a number of new features and opportunities
for regulating SC. However, fabricating andmodifying suchNM to induce specific SC response still represent a significant scientific
and technological challenge. Due to their versatility, plasmas are particularly attractive for the manufacturing and modification of
tailored nanostructured surfaces for stemcell control. In this review,we briefly describe the biological role of SC and themechanisms
by which they are controlled and then highlight the benefits of using a range of nanomaterials to control the fate of SC. We then
discuss how plasma nanoscience research can help produce/functionalise these NMs for more effective and specific interaction
with SCs.The review concludes with a perspective on the advantages and challenges of research at the intersection between plasma
physics, materials science, nanoscience, and SC biology.
1. Introduction
Controlling the fate of stem cells (SC) is one of the most
crucial issues in regenerative biology and medicine. This
versatile type of cell, with promising applications due to their
ability to renew their own population and become other types
of cells (Figure 1(c)), constitutes the fundamental element
of cell therapy. The approach depends upon isolation of SC
cells from a tissue as is the case for adult or somatic SC or
undifferentiated SC from a culture of pluripotent SC then
culture in vitro to generate differentiated mature functional
cells for use in regeneration of aged, injured, and diseased
tissues. However, cell therapy presents challenges that goes
beyond the usual tissue engineering—which combine high-
performance materials and signaling factors with living cells
to restore tissue functions. It involves cells which, when stim-
ulated by specific growth/differentiation factors (e.g., soluble
proteins, insoluble attached proteins, and extracellularmatrix
(ECM) molecules), give rise to a range of heterogeneous
cell types (Figure 1(c)). The success of this approach relies
on knowing which of these factors affects SC fate and how
this interaction occurs. This is a very difficult task and also
depends on how and when the factors are delivered, that is,
affected by the growth factor presentation (conformation)
and time dependent. Studies also show that it is not only the
chemical factors but also the physical interaction between
the biomaterials and SC that influence the behavior of cells
in culture [1, 2] since it directs the forces exerted by cells
on the ECM and are believed to trigger gene activation and
suppression [3–6].
This suggests the important role of controlling the envi-
ronmental material properties (density, stiffness, and archi-
tecture) as well as regarding how exactly the growth/
differentiation factors are presented and delivered (Figure 2).
For this task, biomaterials are being developed to contain
and deliver combinations of factors in a controllable way.
Gels that mimic the ECM, functionalized polymers, inert
metals/alloys, calcium phosphates, nanoparticles, nanofea-
tured surfaces, and several others are just some examples
2 Journal of Nanomaterials
Stem
cell
Ectode
rm
Mesoderm
Endoderm
Lining
of gut
Liver Lung
Muscle
Blood Bones
Skin
Nerves
Adult stem
cells
Skin
Fibroblasts
Defined
factors
Blastocyst(a) (b)
(c)Inner cell mass
Embryonic
stem cells
Induced pluripotent
stem cells
Figure 1: (a) The two sources of pluripotent stem cells. (b) Adult tissue as source of adult (multipotent) stem cell. (c) Differentiation path to
each cell lineage. ((a) and (b) adapted from [7], reprinted with permission fromMacmillan Publishers Ltd.: Nature, Copyright (2009).)
of functional materials that are currently used to study
and control SC fate [1, 7–13]. Although there has been
a considerable advance in the area of gels and scaffolds,
here we focus on nanomaterials (nanoparticles, nanofibers,
and nanostructured surfaces) that can influence selection,
proliferation, and differentiation of SC.
To achieve a greater degree of control, reproducibility,
scalability, and synthetic materials have gained a significant
advantage over naturally occurring materials [1]. In order to
precisely design nanomaterials’ architecture, its mechanical
properties and binding sites for the proper presentation of
ligands, techniques to produce and functionalize these mate-
rials are required. As an attractive alternative to widely used
lithography and chemistry processes, we discuss some of the
new advances in self-assembled plasma-made nanomaterials
[14]. Furthermore, the plasma environment can be used to
produce building blocks for nanoscale assembly and reactive
free radicals for surface modification and in addition can be
used for controlled synthesis and processing of self-organized
nanomaterials [15].
This reviewwill briefly describe in Section 2 the biological
role of SC and some of the knownmechanisms by which they
can be controlled. Section 3 will then highlight the benefits
of using a range of nanomaterials to control the fate of SCs.
Within Section 4, we discuss howplasma nanoscience has the
potential to produce or functionalize these NMs to improve
their interaction with SCs. The review will conclude with
a perspective on the advantages and challenges of research
at the intersection between cell biology, plasma science,
materials science, nanoscience, and engineering.
2. The Biological Role of Stem Cells
2.1. Basic Information. Stem cells (SC) are present in mam-
mals from the beginning of their life until their death. They
form the first cell aggregates, during embryogenesis, and are
able to self-renew their own population and, in order to form
an adult animal, can differentiate into virtually any cell type;
moreover, within the adult mammal tissue, specific adult SC
are also responsible for regenerating mature injured tissues
[1, 7–9]. Due to these two defining properties, namely, self-
renewability and specific differentiation, SC play a pivotal
role in cell therapy for treating/restoring damaged tissues by
direct replacement of diseased cells [1, 8, 9, 17].
Stem cells can be divided into two broad categories:
pluripotent (embryonic SC (ESC) or induced SC (iPSC))
and adult SC. Each of these different SC types is derived
or obtained in different ways [7, 9] (Figures 1(a) and 1(b)).
For example, ESC are derived from cells that are removed
from the inner cell mass of the blastocyst (or embryoblast);
iPSC are a reprogrammed adult cell (from any tissue cell
back to pluripotent stem cells) [21, 22]; and the adult SC are
found in adult tissues within specific anatomical locations
and niches. Adult SCs are found in many tissues and organs
such as the bone marrow, gastrointestinal tract, skin, and
within the central nervous system where their physiological
role is to provide an ongoing supply of mature cells or to
facilitate tissue repair [1, 7–9, 23] (Figure 1(b)). Although
adult SCs’ ability to proliferate and differentiate decreases
with the age of the donor and also with time spent in cell
culture [24, 25], the use of this approach in cell therapy
still remains of great importance as for some tissues it is
relatively easy to isolate and manipulate their resident SCs.
For example, hematopoietic stem cells are readily isolated
from bone marrow or blood and are routinely used for
transplantation [26].
Since 1981, whenmouse ESC (mESC)were first isolated by
Evans and Kaufman [27], the use of these cells in regenerative
medicine has been the subject of great interest [8], especially
in tissue engineering because of the major limitations of
artificial implants [9]. The use of ESC as a cellular model also
helps us to understand early developmental events at the
molecular and cellular level and potentially models of disease
progression and epigenetic regulation of cellular fate [28, 29].
This review will focus on, but is not limited to, SC fate control
by use of synthetic nanomaterials, combined or not with the
defined growth factors (rather than isolating SC or growth
factors themselves). For a discussion of the isolation of SC
from different adult tissues [30–32] and the generation of
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Figure 2: (a) Factors that control stem cell fate in 3D materials, namely, ligand presentation, material structure, and mechanical properties.
(b) Four strategies to be used with 2D materials for controlling stem cells. ((a) is reprinted from [1] Copyright (2009), with permission from
Elsevier. (b) is reprinted from [7] by permission fromMacmillan Publishers Ltd.: Nature Copyright (2009).)
pluripotent cells from multipotent ones through reprogram-
ming, we refer the interested reader to a number of other
reviews [21, 22, 33, 34].
2.2. Controlling the Fate of Stem Cells. Growth factors, which
for the remainder of this paper will include hormones, pro-
teins, and cytokines, have been shown in numerous works
to improve the control over either adult or pluripotent SC.
Theappropriate use of biochemical signals directly added into
the culture medium can maintain or differentiate SC [35–
38]. Retinoic acid (RA), activin-A, TGF-beta, and insulin-
like growth factor 1 (IGF-1) are seen as being responsible
for promoting differentiation of murine ESC (mESC) into
lung epithelial progenitor cells and pancreatic endocrine cells
(alpha, beta, gamma, and delta) [39, 40]. In addition to
the great importance to choose which growth factor to use
for SC control, the cellular niche—the specific tissue site
responsible for regulation of SC fate in the body [9, 41, 42]
(Figure 1(b))—helps us to understand the role of the growth
factor availability and presentation time as well as the need
for a material support for insoluble transmembrane receptor
ligands, as well as its specific presentation to the cells. The
material selection can be based on the desire to maintain an
undifferentiated SC in a culture for a long time or to directly
control cell differentiation [1, 9].
For proper application in tissue engineering or adult
SC-based therapy, it is desirable to choose/manufacture
a biomaterial that closely mimics the “robust spatial and
temporal microenvironment of biophysical and biochemical
signals” (such as chemokines, cytokines, and growth factors,
membrane ligands, and ECMmolecules) [7, 26]. Ideally, this
microenvironment is an artificial version of the stem cell
niche, promoting SC self-renewal or specific differentiation
without loss of the key SC attributes [7, 41–45]. Therefore, to
control SC behavior and achieve homogeneous and efficient
cell differentiation, it is crucial to understand the effects of
the identity, presentation, and density of the differentiation
factors (e.g., ligands and signals), as well as the material
micro- and nanoarchitecture and mechanical properties,
which will be described in the next section [3, 9, 11].
The hydrogel is a well-established culture media that has
been used for decades to mimic the microenvironment of
stem cells in the human body [2, 8, 46–48]. This is due to its
high water content, elasticity, biocompatibility, and the ability
of nutrients and growth factors to diffuse through it [46–49].
Hydrogels, either natural or synthetic, closely resemble the
consistency of the native body tissue by adjusting the hydro-
gels’ crosslinks [8, 50]. Thus they provide efficient adhesion
sites for cells and biological signals and also guidance for cell
orientation and proliferation [3].
These materials can be used instead of feeder-cell layers
for supporting hESC culture and maintenance and were
first reported by Xu et al. [51–53] using natural hydrogels,
with proven ability to differentiate hESCs [54]. Collagen is
an example of a natural hydrogel which is capable of cell
encapsulation [55], support of ESC-derived endothelial cells,
[56] and, in high concentrations, inhibit the embryonic body
(EB) apoptosis and enhance its differentiation [54].Moreover,
collagen in association with fibronectin or laminin was
able to differentiate SC into endothelial and cardiomyocyte
cells, respectively [54]. Furthermore, denaturated collagen
becomes porous gelatin, and is also biocompatible and
extensively used [57, 58]. Other important natural materials
hyaluronic acid and alginate, are both able to encapsulate SC
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and keep them undifferentiated [59] and also differentiate SC
into cardiac [60] and hepatic lineage [61] (Figure 1(c)). Like-
wise, the commercial Matrigel, comprising multiple natural
ECMcomponents, has the ability to direct SC into endothelial
cells [62] and enhanced neovascular formation [63].
2.3. Present-Day Challenges. The use of natural materials,
however, presents some limitations, like batch-to-batch vari-
ations, weak mechanical properties, and manufacturing dif-
ficulties [64]. Synthetic hydrogels, however, are not usually
subject to these limitations and instead offer relatively easy
control over biochemical properties and represent risk-free
media [7–9, 65, 66]. The most commonly used synthetic
biomaterials include polyethylene glycol (PEG), polyvinyl
alcohol (PVA), polylactic acid (PLA), and poly(L)lactic acid
(PLLA), and polylactic-co-glycolic acid (PLGA), which are
microfabricated to be active, degradable, porous, and/or stiff
enough to induce SC differentiation both in vitro and in
vivo [1, 8, 9]. The first biomaterial listed, PEG, is a polymer
composed of nanofibers and is capable of cell encapsulation
and differentiation in numerous tissues (e.g., bone tissue [67,
68]). Also being able tomaintain a neural SC culture, PLA can
be produced with aligned fibers and induce aligned neural
cells [20]. The PLGA usually helps differentiating neural SC
into neural cells [69]. Moreover, when mixed with PLLA,
it also promotes differentiation of ESCs into numerous cell
lineages [70–72].
All these results highlight some important factors about
the medium architecture and applied forces, present in the
natural cell niche, that mechanically control SC fate [2, 73].
Some limitations for the use of hydrogels in the mechanical
control of SC fate, however, include an inability to be syn-
thesised at a stiffness that mimics higher mechanical strength
tissues such as bone, cartilage, and ligaments [8]. Moreover,
although other studies show that hydrogels provide a 3D
structure to support cells, this is not always in the right spatial
dimension (e.g., nanoscale), as that conferred by nanofibrillar
proteins secreted by cells (e.g., collagen) present in cellular
niche [9, 69, 74].
Although the successful application of synthetic hydro-
gels modified with numerous growth factors (GF) to mimic
the SC niche and control the SC fate has been demonstrated,
the strict control of its chemical functionalization, degrada-
tion rates, ligandpresentation, andmechanical properties still
remain challenging.The strategies adopted nowadays involve
the use of nanomaterials [75, 76]. For example, some growth
factors can be adsorbed on nanoparticle surfaces and then
controllably released in the culture medium. Nanomaterials
can also be added to hydrogels in order to control stiffness.
Micro- and nanoscale patterning is now capable of building
materials with specific topographies in order to control the
cell focal interaction in different scales and shapes as well
as providing spots for the attachment of localized ligands
and preventing diffusion [77]. New technologies also provide
better control over the surface chemistry of biomaterials. For
example, functionalization with chemical radicals allows the
attachment of biological factors or may lead to hydrophilic
properties depending on the specific applications.
3. Materials Science Approaches for
Stem Cell Control
3.1. Brief Overview and Critical Factors. Substantial research
efforts in micro- and nanoscale science and technology are
aimed at controlling material topography, surface biochem-
istry, and mechanical properties, in order to mimic and
understand the natural cellular environment. In this way,
many techniques (e.g., chemical vapor deposition, lithogra-
phy, and sputtering) have achieved high fabrication resolu-
tions which made it possible to study the effects of mate-
rial properties on cell-material interactions [78–81]. These
techniques may be used to fabricate nanomaterials, such
as nanoparticles, nanodots, nanostructured surfaces, and
nanoarchitectured scaffolds composed of nanofibers which
can directly affect the cells’ focal attachment and apply forces
that change the cell shape and alignment—important factors
in controlled cell differentiation [2, 73]. Furthermore, some
of these techniques are used to chemically modify the surface
with reactive radicals [82, 83], control degradation rates,
hydrophilicity [84], and ensure proper presentation of the
growth factors, either soluble or attached, thereby directly
influencing SC behavior [7–9, 85].
As extensively reported, the ECM plays a significant role
in controlling cellular behavior by different factors (forces,
topography, growth factors, and ligands) at different levels—
frommacro- to nanoscales [1, 7, 9–11, 86]. Here we emphasize
that materials science approaches hold a major potential
for the recreation of diverse cellular environments, which
can control these factors in order to better mimic and
understand the natural physicochemical ECM features, any
relevant spatial, and temporal scales [7, 8, 10]. The most
advanced approach is to reduce the complex in vivo system
to a controllable simplified systemwhere the desirable factors
(e.g., density, porosity, surface energy, topography, chemical
radicals, surface ligands, and soluble factors) are combined
with the custom designed nanostructures, surfaces, or scaf-
folds [15]. This approach is very promising to increase our
understanding of the most relevant factors for SC control [7].
In the following, we will discuss engineered biomaterials
with nanofeatures, either functionalized or functionalized
with the specific growth factors.This approach helps tomain-
tain SCs “stemness,” which is essential for stem cell therapy
or, alternatively, to differentiate the SCs, which is crucial for
tissue engineering. Nanomaterials will be discussed in order
of increasing dimensionality (from 0D to 3D).
3.2. Zero- and One-Dimensional Nanomaterials. Having at
least two dimensions in the nanoscale, 0D and 1D materials
have huge surface/volume ratios which enable properties
that are different compared to film/bulk materials. These
properties are mainly guided by the materials’ composition,
size, and shape, crystallinity, and how they emerge as a
surface property [76, 87–89]. Depending on the media, some
characteristics, such as the surface charge, hydrophobicity,
particle aggregation, and dissolution, are of great importance
for biological applications. Moreover, these properties regu-
late the interaction of nanomaterials with proteins dispersed
Journal of Nanomaterials 5
in the media [75, 76, 90, 91] and with cells (e.g., binding
receptors, blocking pores, and membrane rupture) [92–94].
Nanoparticles, nanodots, nanowires, carbon nanotubes
(CNT), graphene flakes, and many other zero- and one-
dimensioned materials have found numerous applications
in biomedicine. For example, quantum dots and CNTs have
been used for in vivo imaging [95, 96], and nanofibers and
nanoparticles have been used for gene/drug delivery [97, 98].
Moreover, magnetic nanoparticles were also used to induce
hyperthermal tumor reduction [89]; Ag andAunanoparticles
[99] have bactericidal properties (Ag, Au [99]) whereas TiO
2
,
ZnO, and organic [100] nanoparticles have been shown to
have high UV absorbance. Recently, other versatile materials
have been designed for high-precision sensing [101, 102].
Despite many biomedical-related applications of this
class of nanomaterials, only a few applications on direct
SC differentiation and maintenance have been reported in
the literature. Meanwhile, these small building blocks can
dramatically change the media properties, like hydrogels’
stiffness and polymers’ conductivity. Recently, it was reported
that a hybrid hydrogel-CNTs reinforced scaffold induced a
rapid hMSC proliferation [103]. Their effect was due to the
suitable mechanical properties of the scaffold. These prop-
erties could be achieved by controlling the CNT quantity,
for the formation of specific tissues (e.g., cardiac [104]). The
CNTwere also incorporated in polymer matrices to fabricate
electrically conductive scaffolds, aiming at differentiation and
interaction with neural and cardiac cells via electric signals
[103, 105, 106].
It is well known that nanomaterials in a biological fluid
bind with proteins differently from plain substrates [75,
76, 90], forming an organized and complex (e.g., time-
dependent) structure called the “protein corona.” Some
common proteins, like albumin, immunoglobulin, and fib-
rinogen, are found to bind strongly to CNTs, iron oxide,
and polymeric particles. The properties listed above (e.g.,
surface composition, hydrophobicity, and charge) influence
the protein adsorption and mediate cell-NP interaction (e.g.,
binding, uptake).Therefore, the understanding of the forma-
tion of the protein corona is seen as one of the important
objectives in bio-nanoscience [76, 90–93].
Ranging from microseconds to days [91], the duration of
protein-nanoparticle interaction can be used for controllable
protein delivery through to SC control. It can be directly
introduced into nondegradable (or with difficult degradation
rate control) scaffolds [10, 103] or in vivo [3], as was done
before with other biochemical factors loaded into micro-
spheres [107, 108]. Nanoparticle-protein interaction also rep-
resents a promising application of protein presentation in
diversified conformations [1, 7, 76, 86, 109], which is an
important issue in the SC fate selection.
Using nanomaterials, it is also possible to produce unique
thin films. For example, TiO
2
nanoparticles increase MSC
attachment by altering surface roughness [110]. In another
study, the use of TiN nanoparticles also promotes hMSCs
attachment. More than merely cell attachment, applications
of these nanomaterial films can be extended, targeting
protein binding and presentation as well as controllable
hydrophobicity.
3.3. Two-Dimensional Nanomaterials. Biomaterial designed
surfaces are the simplest, more controllable- and well-
explored model for probing factors for controlling the cell
fate (different ligand presentation strategy can be found in
Figure 2(b)). The development of building and patterning
techniques has made it easier to improve the understanding
of cell biology over the smallest scale of the interaction
between the cells and their natural niches. Furthermore,
this development made it possible to mimic such niches
by appropriate material patterns—from hydrogels using soft
embossing technique to hard ceramics by electron beam
lithography (EBL). The EBL technique—just one example
among many useful techniques—can provide virtually any
topographical nanoarchitecture desired (e.g., cones, tubes,
pitches, and domes) in order to mimic the cell niche.
Cells have the ability to sense and adapt to these envi-
ronmental nanofeatures, using their filopodia [17, 111–113].
Although this has been known, at least since 1952 [114], the
improvement of fabrication techniques over the last decade
has allowed the study of interactions at markedly smaller
scales. Topography combined with material composition and
hardness was shown to exert spatially resolved forces over
the cells’ cytoskeleton [2, 16–18, 115–117], thereby modifying
the cell shape and possibly controlling their fate. Chen et al.
showed that smaller ECM islands change cell morphology
(leading to a more rounded shape), profoundly altering the
actin cytoskeleton and the organization of focal contacts
[115, 116] (Figures 3(a) and 3(b)).
More examples of the options for nanoscale control over
different cell types can be found elsewhere related to the
dimensions and type of the nanostructure (e.g., grooves, pits,
and pores) [16, 18, 112, 113, 118]. For example, an increase in
the apoptotic response of endothelial cells was related to a
decrease in the diameter of the cell’s culture size [16]. Cell fate
is therefore controlled by complex intracellular mechanisms
affected not only by the size and type of nanostructure
but also by symmetry. Highly ordered square nanoarrays
produced by EBL induced low fibroblasts adhesion (Figure 4)
[113]. Moreover, normalised array data show broad downreg-
ulation of genes in fibroblasts cultured on hexagonal pattern,
indicating that mechanical forces lead to changes in gene
regulation [117]. However, the same hexagonal symmetry of
gold nanodots bindingwith integrin receptors has shown that
separation between dots is an important factor to control cell
adhesion and proliferation [119].
These and many other mechanisms can be used to direct
SC growth and differentiation [120].The samemechanisms to
control the cell shape, alignment, and adhesion using mimic-
designed biomaterials were studied in order to control stem
cell proliferation and differentiation [17]. A similar effect of
low adhesion induced by highly ordered nanotopographies
was reported by Dalby et al., where they demonstrated
significantly increased hMSC osteogenic differentiation [18].
Mesenchymal stem cells also show clear alignment and
elongationwhen cultured on a surface with nanogrooves [121,
122]. Yim et al. also reported that the upregulation of neuronal
markers (SOX2, MAP2, neurofilament light peptide, and
tyrosine hydroxylase) was observed and enhanced if the
surface was coated with retinoic acid [121].
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The above studies suggest that nanotopological cues
may be used to direct hMSC and hESC into specific cell
lineages. Acting as a component of the ECM, they change
the cell shape—that is, modify the cytoskeleton structure—by
controlling the number and density of focal adhesion sites in
response to nanostructures shape, size, and symmetry (Fig-
ures 3(c) and 3(d)). A direct consequence is the change in the
cell’s cytoskeleton’s structure which in turn activates specific
genes via mechanotransduction mechanisms (Figure 3(c)),
which are presently not fully understood. Moreover, nanoto-
pography can be used as a spatially well-defined platform
to exert proper presentation of immobilized biochemical
factors (e.g., proteins, ligands, and radical groups) in order to
control cell adhesion,migration, and differentiation [66, 123].
Furthermore, surface nanoarchitecturing can dramatically
change the surface properties, for example, hydrophilicity
[18] and biocompatibility [101].
Graphene is another 2D material being actively studied
for SC support. Although it is a relatively new material, its
surface properties were shown to promote growth and pro-
liferation of hMSC on a range of graphene-coated substrates
[124] and to enhance the differentiation of human neural
stem cells (hNSC) [125]. Moreover, graphene and graphene
oxide were shown to stimulate hMSC differentiation toward
the osteogenic lineage [126–128]. These materials were also
studied as a platform for induced pluripotent SC and induced
differentiation of these cells into an endodermal type [129].
3.4.Three-Dimensional Nanomaterials. Thenatural niche for
tissue-specific adult SCs is not a plane surface. In contrast, it
is three-dimensional and presents biological cues at different
scales and directions (Figure 1(b)) [1, 7–9, 130]. Moreover,
cells are not static and can “feel” the presence of tension and
electrical signals in media. A 3D fibrous scaffold is a viable
model to use as a mimic of body tissue when studying the
proliferation and differentiation of SCs [131–133]. Whilst 2D
materials represent a simple model for isolating the control
factors for SCs in fundamental research, 3Dmaterials possess
a more complex architecture which can be tailored more
precisely for real tissue engineering.The combination of these
scaffolds and adult cells (e.g., fibroblasts and osteoblasts) for
the regeneration of connective tissues is well documented
[9, 134–138].
Commonly made of biopolymers, nanofibrous scaffolds
(NFS) are used to support SC growth (attachment, prolif-
eration, and organization) and differentiation [8, 10, 11, 70].
Recent studies reported that NFS can promote the differenti-
ation of hMSCs even without intentional addition of growth
factors [139]. However, similar to other nanoarchitectured
surfaces, nanofibers can also be designed for molecule/ligand
presentation and delivery [140–142]. In addition to surface
composition andmechanical properties, diffusion of GFs and
migration of cells should be taken into account.
Nevertheless, the results previously discussed for 2D
materials, such as cell alignment to substrate and controlling
cell size and shape, also hold for 3D materials. For example,
using the electrospinning technique, Li et al. produced
and used polymer NFS to induce differentiation of hMSC
into the chondrocyte lineage in order to substitute for the
micromass cell pellet culture [143]. The same group reported
the differentiation of hMSCs from a single patient into
adipogenic, chondrogenic, and osteogenic lineages utilizing
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Figure 4: (a) Self-assembled peptide, micro- and SEM view of the produced scaffold. (b) Matrix elasticity controlling the stem cell fate.
(c) Cells growing on nano- and microfibers scaffolds with visible evidences of cell alignment with fibers produced via electrospinning. ((a)
reprinted from [19] with permission from AAAS., (b) reprinted from [2], Copyright (2006), with permission from Elsevier., (c) reprinted
from [20], Copyright (2005), with permission from Elsevier).
the same NF matrix [144]. The same technique was also used
to produce aligned nano- and micro-FS [20]. Neural SCs
cultured on that media grew such that they were aligned
with the fibers, independently of their diameter (Figure 4(c)).
However, the differentiation rates were higher (as evidenced
by a strong protein expression) on the nanofibrous rather
than on the microfibrous scaffolds [20]. Importantly, not
only differentiation but SC proliferation was reported using
synthetic polyamide NF matrix [133].
A notable advantage of these materials is the reasonably
high level of control over elasticity, an important character-
istic due to the strong influence over the SC fate [2, 145].
This property is hard to control when using 2D materials
and can be set closer to the elasticity of biological tissues
using nanofibers [7]. Moreover, introduction of carbon nan-
otubes/fibers into polymeric matrices can lead to an increase
in mechanical properties, electrical conductivity, and reac-
tivity of the biomaterials [146, 147]. Recently, Subramony
et al. [134] showed the time control ofmechanical stimulation
during MSC growth and its effects on cell differentiation.
Mechanical tension combined with the matrix alignment
led to the development of fibroblasts in vitro without any
significant chemical influence.
Instead of polymers, another two classes of materials
that are used for NF 3D scaffolds deserve specific attention,
namely, carbon nanotubes/fibers and self-assembled peptide
nanofibers (Figure 4(a)). Carbon nanomaterials have already
been discussed in this review. Nevertheless, nanofibers of
this abundant and nontoxic material have been effective in
differentiating neural stem cells as well as offering good
electrical conductivity, high reactivity [146], and increased
absorption of laminin [148]. On the other hand, some
peptide sequences known to direct SC differentiation can
self-assemble in order to form a high-density NF scaffold
[19]. Some useful characteristics of these peptide scaffolds
are the high water content and the diffusion of nutrients,
bioactive factors, and oxygen sufficient for the survival of
large numbers of cells for extended periods of time [19].
4. Potential Use of Plasmas for Materials for
Stem Cell Control
4.1. Plasma-Based Process Overview. Plasma-based synthesis
and processing of nanomaterials are an interdisciplinary
research field [14, 15, 149]. A wide range of applications
resulted from the control over the properties involved in
plasma-based systems such as source power, frequency, and
chemistry. A range of species such as ions, electrons, atoms,
and radicals are present in a plasma discharge. The principal
property of plasma processes is the capability to deliver these
species at a desired substrate with controllable energy, thus
enabling nanoscale self-assembly [150–155] and deterministic
fabrication of nanomaterials [14, 15, 152, 156–164]. Some
examples of plasma-produced nanomaterials are presented in
Figure 5. Interestingly, these carbon-based nanostructures—
vertically aligned graphene and carbon nanotubes—can only
be obtained via plasma-based processes [165].
The focus on direct medical applications of plasmas—
where the related substrate can be a living tissue—is also
increasing [166, 167]. For example, low-temperature plasmas
have been used for treating diseases in animal models [88,
168, 169]. Reactive species produced in low-temperature
plasma (e.g., free radicals as well as reactive oxygen and
nitrogen species (ROS/RNS) such as O, OH, H
2
O
2
, O
3
, NO,
and NO
2
) [169, 170]) have a fundamental role in chemical
reactions, as they can be used to regulate the level of ROS
and RNS in intracellular space in order to control cell fate
[88, 167]. The role of ROS and RNS in cell control is widely
studied; amongst other things they have been shown to
influence cell “stemness” [171] and proliferation [172, 173].
Recently, atmospheric-pressure plasma jets showed a
special selectivity, killing cancer cells without affecting nor-
mal cells [174]. These and similar (e.g., dielectric barrier
discharges) devices were also used under different doses to
inactivate pathogens and microorganisms such as bacteria,
fungi, and viruses [168, 169, 175]. This type of plasma
has found numerous applications in medicine and several
others such as sterilization of surgical instruments, skin,
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Figure 5: SEM of plasma-produced carbon nanostructures. (a) Vertical aligned graphene (VAG) on a TEM grid. (b) Detail of VAG. (c) Side
view of high-density vertical aligned carbon nanotubes (VACN). (d) Top view of low-density VACN tips. Original research results from the
Plasma Nanoscience Laboratories at CSIRO.
and wound disinfection/healing [88, 176–180]. Atmospheric
pressure plasmas have also been demonstrated to support
“plasma bullets” [181, 182]; such exotic structures are likely to
lead to a range of promising medical applications and should
be the subject of further investigation.
Control over SC fatemediated by plasmas is also possible;
for example [183], atmospheric-pressure room-temperature
plasmas can effectively induce in vitro differentiation of
neural stem cells (NSCs) predominantly into neuronal lin-
eage. After plasma treatment, the murine NSC exhibited
rapid proliferation and differentiation into neurons with high
efficiency.
There are, however, potential disadvantages associated
with the use of plasmas for direct medical application;
these are largely related to the presence of plasma-generated
energetic ROS/RNS and UV radiation [184]. Studies have
shown that, depending on the specific conditions (i.e., plasma
dose/irradiation and cell type), plasmas may affect cell prop-
erties (i.e., adhesion, membrane permeability, migration, and
apoptosis/necrosis) and possibly damage DNA and modify
proteins [184]. Further study and clinical trials are required
before practical use of plasmas as direct medical tools.
Plasmas may also be used to fabricate micro- and nanos-
tructures (see Figure 5) as well as appropriately functional-
ized surfaces, suitable for SC control. The aim of the rest of
this section is to track where plasma technologies have an
implication over materials production and modification for
stem cell control and highlight where it could have potential
uses.
4.2. Plasma-Based Nanofabrication. The existence of ener-
getic species in plasmas makes it suitable for dry etching
applications andmany other materials synthesis and process-
ing [152, 157, 159, 163, 185]. These techniques can produce
patterns in hard materials at micro- and nanoscales. These
patterns in turn can be used to control the alignment and
shape of SCs. The material removed from a target using
plasmas can also be used for functional thin film deposition,
with almost no restriction over the target composition or
substrate shape—which is an advantage for coating 3D
materials [14, 15, 149, 186]. Moreover, the properties of these
thin films can be precisely tailored, for example, to enable
degradation after use [159, 187]. Other considerations for
biological applications are the production time and cost [16],
which can be reduced in plasma processes [151, 153, 188].
The applications, namely, etching, deposition and, surface
modification, are the most common in literature, although
plasma-based processes are capable of producing a variety
of nanomaterials [151, 189], namely, nanoparticles [190, 191],
nanodots [155, 192], and various allotropes of carbon (e.g.,
nanodiamond [15], nanotubes [158, 189], nanocones [193],
nanowalls, and graphene [102, 160, 161, 194]). Plasma tech-
niques also provide the control over the properties of these
nanomaterials (e.g., size, shape, and surface reactivity) [99,
152, 157, 162, 163, 195]. As discussed above, these properties are
essential to bind proteins and cells, as well as for the delivery
of specific (e.g., differentiation) factors in order to control
the SC fate. Moreover, due to the unique ability to dissociate
molecules (e.g., hydrogen), the control over some properties
is not achievable by other techniques such as neutral gas-
based CVD or by wet chemistry routes [165].
The control over the nanostructural properties is related
to the plasma ability to generate and concentrate building
units (BU) of nanoscale matter [15, 99]. Moreover, these
BU can be directly delivered to a substrate and build a
wide range of complex architectures discussed previously to
mimic the SC natural niche and control cell fate. The plasma
environments have specific features and control self-assembly
of nanostructures into patterns and arrays (often termed
“mask-less”). Plasma processes have also been reported to
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lead to a sustainable energy saving and reduction of green-
house emissions. Interestingly, carbon nanotubes and other
one-dimensional nanostructures show pronounced vertical
alignment which is not common to thermal CVD [165].
For the same reason, plasma-based technologies have
long been reported as an effective route for surface treatment
[15]. The importance of this fact is, for example, the ability
to chemically improve the biocompatibility of the surface
by increasing its hydrophilicity, which in turn increases the
cell proliferation [8, 158, 163]. Moreover, several limitations
(e.g., control over chemical properties and difficulties in
sterilization) could be overcome by plasma-based techniques.
Furthermore, plasma-based techniques were used to func-
tionalize important nanomaterials such as CNTs leading to
better substrates for the enhancement of cell growth and
proliferation [196].
Regarding the control of SC fate, it is well known that the
proliferation (without differentiation) or the differentiation
to desired lineages requires both growth factors and, for
some specific SC, mechanical stimulation. Several strategies
can be followed to reach this goal, for example, produc-
tion of specific tailored nanostructures with or without
bound/immobilised growth factors that directly promote
SC expansion or controlled differentiation. These nanos-
tructures can be added to hydrogels/nanoscaffolds in order
to temporally control the delivery of GFs and migration
of cells. Surfaces can also be plasma-tailored with desired
nanostructures tomechanically guide the SC via focal contact
or be used as binding point to ligands/chemical radicals or
both, leading to SC proliferation/differentiation according to
the input stimulus.
An example involving a plasma-treated nanostructure
coated with a specific GF was reported by Arnold et al.
[119]. In order to understand the role of a precise molecular
arrangement on cell response, a substrate was patterned with
Au nanodots (<8 nm), highly ordered with controllable dis-
tances, via self-assembly of diblock copolymermicelles. After
the assembly of the nanodots, the polymer was completely
removed by the plasma treatment and the dot-patterned sub-
strate was functionalized with a specific peptide (c(RGDfK)),
which has a high affinity to the 𝛼]𝛽-integrin. Due to the
small surface area of the nanodot, only one integrin can
attach to each dot and the effect of the arranged binding
sites could be studied. Such an approach is powerful as it
enables control over the presentation of mass amounts of
specific signals/ligands at precise spatial locations and size
scales and therefore an ability to dissect how cells respond
to variations in ligand density. There is great potential to
exploit this approach to critically examine the presentation of
defined amounts of combinations of biological signals to stem
cells.We predict that sophisticated nanoengineering based on
plasma generated biomaterials will underpin a new era in cell
culture.
5. Conclusions and Challenges for
Future Research
In this review, we have discussed sources and applications of
SCs and themechanisms by which they can be controlled and
subsequently, the use of nanomaterials to control SCs. We
have pointed out the properties that make low-temperature
plasmas a suitable tool to use in the production and func-
tionalization of these NMs for more effective and specific
interaction with SCs, both through direct treatment and as
a versatile nanofabrication tool [15].
Due to the many unique characteristics of low-temper-
ature plasmas, we believe that the direct use of plasmas,
especially atmospheric plasmas, should be considered as a
viable strategy to direct SC differentiation. Plasmas as a
nanofabrication tool should be focused on developing “lab on
a chip” devices as suitable platforms for the differentiation of
SCs into any cell lineage throughmechanical and/or electrical
stimulus.
Tissue engineering and SC biology can benefit greatly
from advances in plasma nanoscience [15]. Nanomaterial
design is leading to a greater degree of control over cell
attachment and migration in order to grow multilevel tissues
(or organs, e.g., skin). This control also contributes to basic
studies on mimicking ECM properties and ligands quantity
and presentation as well as elucidating the role of time in
growth factors delivery.
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